~~<i id='3DE2E3CCD7'><strike id='3DE2E3CCD7'><tt id='3DE2E3CCD7'><pre id='3DE2E3CCD7'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：knowledge 2025-10-01 03:57:15 Page View：26

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Just how powerful is the placebo effect?
Next article： Peter Hotez and the public health issue of online harassment

explore

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

More doctors should go into startup world

AdobeInmydecadelivinginSiliconValleyasadigitalhealthjournalistandnowaninvestor,Ican’ttellyouhowmanyt

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

PascalSoriot,thechiefexecutiveofficerofAstraZeneca.WinMcNamee/GettyImagesTheparticipantwhotriggereda